ArticleCardiovascular and interventional radiology2026
Radiation Dose, Outcomes, and Trends of CT-Guided Osteoid Osteoma Ablation in Pediatric Patients: An Analysis of the Registry of the German Society for Interventional Radiology and Minimally Invasive Therapy.
Article in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- CT-Guided Transmandibular Cryoablation as Salvage Therapy for Recurrent Mandibular Osteoid Osteoma.Cardiovascular and interventional radiology · 2026Article
- From Variability to Accountability: Rethinking Radiation Exposure in Pediatric Osteoid Osteoma Ablation.Cardiovascular and interventional radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study evaluated radiation dose parameters, clinical outcomes, and national trends in conventional CT-guided pediatric osteoid osteoma ablation. MATERIALS AND
methodsWe retrospectively analyzed data from the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) registry (2019-2024). Patients ≤ 18 years with available Dose Length Product were included. Radiation dose, clinical outcome, and ablation modality were assessed. Benchmarks were defined using percentiles stratified by age and anatomical location.
resultsA total of 166 pediatric patients (mean age 13.45 years; 59 female) were included. The median Dose Length Product was 132.00 (Q1: 53, Q3: 314) mGycm, 222.00 (Q1: 64.50, Q3: 485) mGycm for axial skeleton, and 124.00 (Q1: 51, Q3: 297) mGycm for extremity ablations. Technical success was 99.4% (partial technical success 0.60%), early clinical success was 58.43% (39.76% not assessable, 1.81% no improvement), and the complication rate was 1.81%. After additional age stratification and exclusion of very small groups (n < 5), Dose Length Product Q1; Q3 values were: axial skeleton 10-14 years 53; 504 mGycm (n = 6), 15-18 years 71; 483 mGycm (n = 17); extremities 5-9 years 55; 184 mGycm (n = 19), 10-14 years 43; 256 mGycm (n = 58), 15-18 years 50; 370 mGycm (n = 61). Radiofrequency ablation was most frequently applied (71.08%), followed by microwave ablation (26.51%), cryoablation (1.81%), and others (0.60%).
conclusionThis multicenter analysis provides proposed pediatric benchmarks for radiation exposure during conventional CT-guided osteoid osteoma ablation, which demonstrated excellent safety and technical success, supporting its role as standard therapy.
Indexed as
Identifiers
41876692What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.